Intravenous Infusions

What Intravenous Infusions does

Intravenous Infusions PLC (IIL) is a Ghanaian pharmaceutical manufacturer founded in 1969 and publicly listed on the Ghana Stock Exchange under the ticker IIL. The company produces and distributes intravenous (IV) fluids, small volume injectables, and the narcotic analgesic Pethidine, for which it is the sole producer in the West African sub-region. Its headquarters and primary manufacturing facility are located in Koforidua, Ghana, with a depot network spanning Accra, Takoradi, Kumasi, and Tamale to serve domestic customers.

The company's revenue is generated through direct sales of pharmaceutical products to hospitals and pharmacies across Ghana, with export sales into Ivory Coast, Mali, Niger, Togo, and Nigeria. Customers are reached through a depot-based direct distribution model rather than third-party intermediaries, and pricing is conducted through institutional procurement processes typical of healthcare supply. The company is FDA-approved, holds cGMP compliance, and is constructing a new factory to support capacity expansion and product diversification into medical consumables and disposables, supplemented by a contract manufacturing arrangement with an Indian pharmaceutical partner to introduce ten new products.

In its most recent disclosed fiscal year (2021), IIL recorded 9.69% revenue growth, GHS 1,432,464 profit before tax, and 24.68% growth in total assets. The company is pursuing a GHS 50 million Rights Issue proposed at the 2025 Annual General Meeting to fund recapitalization and expansion, having previously raised GHS 5.94 million via private placement in 2018.

Name

Intravenous Infusions

Legal name

INTRAVENOUS INFUSIONS PLC

Website

https://iil.com.gh

Company type

Public

Founded year

1969

Operating status

Operating

Headcount range

101–250 employees

Short description

Intravenous Infusions PLC is a Ghanaian pharmaceutical manufacturer (founded 1969, Ghana Stock Exchange: IIL) that produces IV fluids, small volume injectables, and Pethidine — the last solely within West Africa — supplying hospitals and pharmacies across Ghana and exporting to neighboring West African countries through a five-depot distribution network.

Ownership category

akta.pro rank

Headquarters

HQ city

Koforidua

HQ country

Ghana

HQ region

Africa

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and distribution of intravenous fluids and small volume injectables to hospitals, pharmacies, and healthcare facilities across Ghana and West Africa.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Intravenous Infusions PLC manufactures and distributes intravenous (IV) fluids and small volume injectables for hospitals and pharmacies in Ghana and the West African sub-region. It is the oldest and single largest producer of IV fluids in Ghana and the sole producer of Pethidine in West Africa, supplying essential pharmaceuticals for hydration, electrolyte replacement, and medication administration.

Product overview

Intravenous Infusions PLC operates as a pharmaceutical manufacturing company with a portfolio centered on intravenous fluids as its core product, supplemented by small volume injectables and expanding into medical consumables and disposables. The company produces and distributes IV fluids to hospitals and pharmacies across Ghana and West Africa, making it the single largest producer and oldest IV fluids manufacturer in the sub-region. The product portfolio includes: (1) IV Fluids - the dominant production line serving hydration and electrolyte therapy needs; (2) Pethidine - a narcotic analgesic with sole producer status in West Africa; (3) Small Volume Injectables including Quinine Dihydrochloride; and (4) Medical Consumables and Disposables - a new expansion category. The company is also pursuing contract manufacturing arrangements with an Indian company to introduce ten additional products.

Differentiator

Problem solved

Functional benefit

Products and services

• Intravenous Fluids (IV Fluids) Intravenous fluids for hydration, electrolyte replacement, and medication administration delivered directly into the circulatory system. The dominant production offering, supplied to hospitals and pharmacies across Ghana and exported across West Africa.
• Pethidine Pethidine, a narcotic analgesic, produced by Intravenous Infusions PLC as the pioneering and sole producer in Ghana and the broader West African sub-region.
• Small Volume Injectables Small volume injectable medications, historically including Chloroquine Phosphate injection and Quinine Dihydrochloride injection, supplied for hospital and clinical use. Quinine Dihydrochloride was initially targeted for export and gained local market acceptance.
• Medical Consumables and Disposables Medical consumables and disposables that the company is expanding into as part of a diversification strategy to complement its core pharmaceutical manufacturing and address export market opportunities.

Quantifiable outcome

• 9.69% revenue growth in 2021
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered minor and core.

• GCB Bank Limited (Share Registry)minorOthers · 8 August 2025GCB Bank Limited serves as the Share Registry for Intravenous Infusions PLC, handling shareholder services and proxy voting for AGMs.
• Noguchi Memorial Institute for Medical ResearchminorOthersIntravevenous Infusions Limited (IIL) donated one million liters of IV fluid to Noguchi Memorial Institute for Medical Research, Ghana's premier medical research institution.
• Indian Pharmaceutical Company (Unnamed)coreStrategic or Co-development PartnerContract manufacturing arrangement with an Indian pharmaceutical company to introduce 10 new products to the company's product mix, supporting product diversification strategy.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Cipla: Indian global pharmaceutical major with strong presence in African markets producing generics including injectables. Comparable as the partner profile behind IIL's contract manufacturing arrangement and a competitor for African pharmaceutical contracts.
• B. Braun Melsungen: German medical device and pharmaceutical company with one of the world's largest IV solutions and infusion therapy portfolios. Comparable as a broad incumbent in sterile IV fluid manufacturing with presence across global hospital channels, including emerging markets.
• Baxter International: Global leader in IV solutions, infusion pumps, and sterile pharmaceuticals. Comparable as the dominant global producer of IV fluids and small-volume injectables, representing both a competitive threat and the benchmark for IIL's product categories.
• Fresenius Kabi: Specializes in IV fluids, infusion solutions, and clinical nutrition products globally. Highly comparable to IIL in its IV solutions business and represents a multinational competitor that could enter West African markets.

Emerging players

• AdvaCare Pharma: Manufactures and distributes generic pharmaceuticals including IV fluids with significant operations across Africa, Asia, and Latin America. Comparable as a peer targeting emerging markets with IV fluids and small-volume injectables, competing for similar institutional buyers.
• Julphar (Gulf Pharmaceutical Industries): Middle East-based generic pharmaceutical manufacturer with exports into African markets producing IV fluids and injectables. Comparable as an emerging international player expanding into African institutional pharmaceutical channels with overlapping product categories.

Direct peers

• Starwin Products (Ghana): Ghanaian pharmaceutical manufacturer producing generic medicines including injectables and hospital supplies. Most directly comparable as a domestic Ghanaian competitor pursuing similar customers, distribution model, and regulatory pathway.

Regional players

• Cosmos Pharmaceutical Africa: Kenya-based pharmaceutical manufacturer producing generic and OTC medicines including IV fluids across East Africa. Comparable as an African regional pharma manufacturer with overlapping hospital product lines and similar frontier-market dynamics.
• Evans Medical PLC: Nigerian pharmaceutical company producing a range of generics including IV fluids and injectables. Comparable as a West African regional pharma manufacturer with similar product portfolio and similar emerging-market distribution dynamics.
• Emzor Pharmaceutical Industries: One of Nigeria's largest pharmaceutical manufacturers producing a wide range of generics including IV fluids. Comparable as a regionally dominant African pharma manufacturer operating in an adjacent West African market with overlapping product categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/InfusionsPlc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intravenous Infusions